« Back to news listing

St. Jude, C.R. Bard Make Medical Device Acquisitions

Leading medical-device companies St. Jude Medical (STJ) and C.R. Bard (BCR) both announced tuck-in acquisitions Monday morning to fill out their product lines.

St. Jude paid $171 million upfront for Switzerland’s Endosense, and could pay up to $161 million more if that firm’s TactiCath ablation catheter meets a regulatory milestone. The device is used in surgeries to treat heart arrhythmias, in which a catheter is fed into the heart.

Bard announced its $200 million buyout of privately held Medafor on Monday.  Medafor sells the Arista plant-based hemostat, a device to control bleeding during surgery.

Read entire article: http://news.investors.com/technology/081913-667952-stj-bcr-acquire-new-technologies.htm

« Back to news listing